| Status: Assessment pending - company submission requested | |
Treatment of Friedreich’s ataxia (FA) in adults and adolescents aged 16 years and older. |
|
Medicine details |
|
| Medicine name | omaveloxolone (Skyclarys®) |
| Formulation | 50 mg hard capsule |
| Reference number | 5337 |
| Indication | As above |
| Company | Biogen Idec Ltd |
| BNF chapter | Central nervous system |
| Assessment type | Full |
| Status | Assessment pending - company submission requested |
| Scrutiny Panel meeting date | 16/04/2026 |